Dr. Banafsheh Rastegari is a distinguished cell/molecular biology researcher with extensive experience in cancer biology, nanotechnology, and drug delivery systems. She has made significant contributions to interdisciplinary research, particularly in the development of innovative therapeutic strategies for combating cancer.
Dr. Rastegari began their academic career at Shiraz University. During this time, she isolated and purified a bacterial-derived native protein with catalytic activity to degrade pectin. This foundational work enabled her to master molecular techniques such as gene cloning, protein overexpression, and advanced chromatography methods (Size exclusion, Ion exchange, and Affinity chromatography). Building on this expertise, Dr. Rastegari completed their Ph.D. at Shiraz University. Her doctoral research focused on understanding the pathophysiological mechanisms of cancer and other diseases through the application of nanoparticles and hydrogels. One of her key projects investigated the drug delivery role of Prodigiosin, targeting lectin receptors to combat breast, lung, and liver cancers. During her Ph.D., she served as a visiting student in the Chemical Engineering department at McMaster University under Prof. Sheardown's supervision. Also, she got undertook a two-year postdoctoral program in atherosclerosis Immunology. Now, As a Research Assistant Professor, she has mentored numerous master’s /Ph.D. students in chemical engineering, and comparative biomedicine.
Dr. Banafsheh Rastegari is a distinguished cell/molecular biology researcher with extensive experience in cancer biology, nanotechnology, and drug delivery systems. She has made significant contributions to interdisciplinary research, particularly in the development of innovative therapeutic strategies for combating cancer.
Dr. Rastegari began their academic career at Shiraz University. During this time, she isolated and purified a bacterial-derived native protein with catalytic activity to degrade pectin. This foundational work enabled her to master molecular techniques such as gene cloning, protein overexpression, and advanced chromatography methods (Size exclusion, Ion exchange, and Affinity chromatography). Building on this expertise, Dr. Rastegari completed their Ph.D. at Shiraz University. Her doctoral research focused on understanding the pathophysiological mechanisms of cancer and other diseases through the application of nanoparticles and hydrogels. One of her key projects investigated the drug delivery role of Prodigiosin, targeting lectin receptors to combat breast, lung, and liver cancers. During her Ph.D., she served as a visiting student in the Chemical Engineering department at McMaster University under Prof. Sheardown's supervision. Also, she got undertook a two-year postdoctoral program in atherosclerosis Immunology. Now, As a Research Assistant Professor, she has mentored numerous master’s /Ph.D. students in chemical engineering, and comparative biomedicine.